Article Versions Notes

Awida Z, Bachar A, Saed H, Gorodov A, Ben-Califa N, Ibrahim M, Kolomansky A, Iden JA, Graniewitz Visacovsky L, Liron T, et al. The Non-Erythropoietic EPO Analogue Cibinetide Inhibits Osteoclastogenesis In Vitro and Increases Bone Mineral Density in Mice. International Journal of Molecular Sciences. 2022; 23(1):55. https://doi.org/10.3390/ijms23010055

Awida, Zamzam, Almog Bachar, Hussam Saed, Anton Gorodov, Nathalie Ben-Califa, Maria Ibrahim, Albert Kolomansky, Jennifer Ana Iden, Liad Graniewitz Visacovsky, Tamar Liron, and et al. 2022. "The Non-Erythropoietic EPO Analogue Cibinetide Inhibits Osteoclastogenesis In Vitro and Increases Bone Mineral Density in Mice" International Journal of Molecular Sciences 23, no. 1: 55. https://doi.org/10.3390/ijms23010055

Awida, Z., Bachar, A., Saed, H., Gorodov, A., Ben-Califa, N., Ibrahim, M., Kolomansky, A., Iden, J. A., Graniewitz Visacovsky, L., Liron, T., Hiram-Bab, S., Brines, M., Gabet, Y., & Neumann, D. (2022). The Non-Erythropoietic EPO Analogue Cibinetide Inhibits Osteoclastogenesis In Vitro and Increases Bone Mineral Density in Mice. International Journal of Molecular Sciences, 23(1), 55. https://doi.org/10.3390/ijms23010055